Skip to main content

Articles

Page 1 of 16

  1. To analyse the predictive effect of a nomogram combining dual-layer spectral computed tomography (DSCT) quantitative parameters with typical radiological features in distinguishing benign micro-nodule from thy...

    Authors: Zuhua Song, Qian Li, Dan Zhang, Xiaojiao Li, Jiayi Yu, Qian Liu, Zongwen Li, Jie Huang, Xiaodi Zhang and Zhuoyue Tang
    Citation: Cancer Imaging 2023 23:13
  2. Metastatic bone disease (MBD) is the most common form of metastases, most frequently deriving from prostate cancer. MBD is screened with bone scintigraphy (BS), which have high sensitivity but low specificity ...

    Authors: Abdalla Ibrahim, Akshayaa Vaidyanathan, Sergey Primakov, Flore Belmans, Fabio Bottari, Turkey Refaee, Pierre Lovinfosse, Alexandre Jadoul, Celine Derwael, Fabian Hertel, Henry C. Woodruff, Helle D. Zacho, Sean Walsh, Wim Vos, Mariaelena Occhipinti, François-Xavier Hanin…
    Citation: Cancer Imaging 2023 23:12
  3. Accurate staging and response assessment are essential for prognosis and to guide treatment in patients with lymphoma. The aim of this study was to compare the diagnostic performance of FDG PET/MRI versus FDG ...

    Authors: Vijay Mistry, Justin R. Scott, Tzu-Yang Wang, Peter Mollee, Kenneth A. Miles, W. Phillip Law and Greg Hapgood
    Citation: Cancer Imaging 2023 23:11
  4. The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are a first-line therapy for non-small cell lung cancer (NSCLC) with EGFR mutations. Approximately half of the patients with EGFR-muta...

    Authors: Chia-Feng Lu, Chien-Yi Liao, Heng-Sheng Chao, Hwa-Yen Chiu, Ting-Wei Wang, Yen Lee, Jyun-Ru Chen, Tsu-Hui Shiao, Yuh-Min Chen and Yu-Te Wu
    Citation: Cancer Imaging 2023 23:9
  5. The evaluation of treatment response according to METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) criteria is an important but time-consuming task for patients with advanced prostate canc...

    Authors: Xiang Liu, Zemin Zhu, Kexin Wang, Yaofeng Zhang, Jialun Li, Xiangpeng Wang, Xiaodong Zhang and Xiaoying Wang
    Citation: Cancer Imaging 2023 23:7
  6. Deep-learning-based computer-aided diagnosis (DL-CAD) systems using MRI for prostate cancer (PCa) detection have demonstrated good performance. Nevertheless, DL-CAD systems are vulnerable to high heterogeneiti...

    Authors: Lei Hu, Caixia Fu, Xinyang Song, Robert Grimm, Heinrich von Busch, Thomas Benkert, Ali Kamen, Bin Lou, Henkjan Huisman, Angela Tong, Tobias Penzkofer, Moon Hyung Choi, Ivan Shabunin, David Winkel, Pengyi Xing, Dieter Szolar…
    Citation: Cancer Imaging 2023 23:6
  7. To investigate the role of preoperative body composition analysis for muscle and adipose tissue distribution on long-term oncological outcomes in patients with middle and low rectal cancer (RC) who received cu...

    Authors: Jiyang Liu, Xiongfeng Yu, Xueqing Huang, Qingquan Lai and Jieyun Chen
    Citation: Cancer Imaging 2023 23:5
  8. PET/MRI is an emerging imaging modality which enables the evaluation and quantification of biochemical processes in tissues, complemented with accurate anatomical information and low radiation exposure. In the...

    Authors: Stefan Prado-Wohlwend, Mónica Ballesta-Moratalla, Irene Torres-Espallardo, María Isabel del Olmo-García, Pilar Bello-Arques, Consuelo Olivas-Arroyo and Juan Francisco Merino-Torres
    Citation: Cancer Imaging 2023 23:4
  9. Early diagnosis of prostate cancer improves its prognosis, while it is essential to upgrade screening tools. This study aimed to explore the value of a novel functional magnetic resonance imaging (MRI) techniq...

    Authors: Lu Yang, Lei Wang, Yuchuan Tan, Hanli Dan, Peng Xian, Yipeng Zhang, Yong Tan, Meng Lin and Jiuquan Zhang
    Citation: Cancer Imaging 2023 23:3
  10. The aim of this study is to investigate the impact of 18F-FDG PET/CT on prognosis of stage II invasive ductal carcinoma (IDC) of the breast primarily treated with surgery.

    Authors: Hye Lim Park, Sea-Won Lee, Ji Hyung Hong, Jieun Lee, Ahwon Lee, Soo Jin Kwon, Sonya Youngju Park and Ie Ryung Yoo
    Citation: Cancer Imaging 2023 23:2
  11. A comparative retrospective study to assess the impact of PSMA Ligand PET/MRI ([68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 PET/MRI) as a new method of target delineation compared to conventional imaging on whole-...

    Authors: Lin-Lin Liu, Lei-Lei Zhu, Zhen-Guo Lu, Jun-Die Sun, Jun Zhao, Hai-Feng Wang and Zuo-Lin Xiang
    Citation: Cancer Imaging 2023 23:1
  12. The injection activity of tracer, acquisition time, patient-specific photon attenuation, and large body mass, can influence on image quality. Fixed acquisition time and body mass related injection activity in ...

    Authors: Jie Xiao, Haojun Yu, Xiuli Sui, Guobing Liu, Yanyan Cao, Zhao Yanzhao, Yiqiu Zhang, Pengcheng Hu, Dengfeng Cheng and Hongcheng Shi
    Citation: Cancer Imaging 2022 22:78
  13. To evaluate the performance of diffusion-relaxation correlation spectrum imaging (DR-CSI) with support vector machine (SVM) in detecting prostate cancer (PCa).

    Authors: Xiaobin Wei, Li Zhu, Yanyan Zeng, Ke Xue, Yongming Dai, Jianrong Xu, Guiqin Liu, Fang Liu, Wei Xue, Dongmei Wu and Guangyu Wu
    Citation: Cancer Imaging 2022 22:77
  14. To find semi-quantitative and quantitative Positron Emission Tomography/Magnetic Resonance (PET/MR) imaging metrics of both tumor and non-malignant lymphoid tissue (bone marrow and spleen) for Progression Free...

    Authors: Therese Sjöholm, Alexander Korenyushkin, Gustav Gammelgård, Tina Sarén, Tanja Lövgren, Angelica Loskog, Magnus Essand, Joel Kullberg, Gunilla Enblad and Håkan Ahlström
    Citation: Cancer Imaging 2022 22:76
  15. Texture analysis derived from computed tomography (CT) can provide clinically relevant imaging biomarkers. Node-RADS is a recently proposed classification to categorize lymph nodes in radiological images. The ...

    Authors: Hans-Jonas Meyer, Benedikt Schnarkowski, Johanna Pappisch, Teresa Kerkhoff, Hubert Wirtz, Anne-Kathrin Höhn, Sebastian Krämer, Timm Denecke, Jakob Leonhardi and Armin Frille
    Citation: Cancer Imaging 2022 22:75
  16. To construct a model based on magnetic resonance imaging (MRI) features and histological and clinical variables for the prediction of pathology-detected extracapsular extension (pECE) in patients with prostate...

    Authors: Adalgisa Guerra, Filipe Caseiro Alves, Kris Maes, Steven Joniau, João Cassis, Rui Maio, Marília Cravo and Helena Mouriño
    Citation: Cancer Imaging 2022 22:74
  17. Response assessment in the context of immunomodulatory treatments represents a major challenge for the medical imaging community and requires a multidisciplinary approach with involvement of oncologists, radio...

    Authors: E. Lopci, N. Aide, A. Dimitrakopoulou-Strauss, L. Dercle, A. Iravani, R. D. Seban, C. Sachpekidis, O. Humbert, O. Gheysens, A. W. J. M. Glaudemans, W. A. Weber, A. D. Van den Abbeele, R. L. Wahl, A. M. Scott, N. Pandit-Taskar and R. J. Hicks
    Citation: Cancer Imaging 2022 22:73
  18. High-risk differentiated thyroid cancer (DTC) needs effective early prediction tools to improving clinical management and prognosis. This cohort study aimed to investigate the prognostic impact of 99mTc-PEG4-E[PE...

    Authors: Yiqian Liang, Xi Jia, Yuanbo Wang, Yan Liu, Xiaobao Yao, Yanxia Bai, Peng Han, Si Chen, Aimin Yang and Rui Gao
    Citation: Cancer Imaging 2022 22:72
  19. Biologically targeted radiation therapy treatment planning requires voxel-wise characterisation of tumours. Dynamic contrast enhanced (DCE) DCE MRI has shown promise in defining voxel-level biological characte...

    Authors: Hayley M. Reynolds, Sirisha Tadimalla, Yu-Feng Wang, Maryam Montazerolghaem, Yu Sun, Scott Williams, Catherine Mitchell, Mary E. Finnegan, Declan G. Murphy and Annette Haworth
    Citation: Cancer Imaging 2022 22:71
  20. This review describes the main benefits of using long axial field of view (LAFOV) PET in clinical applications. As LAFOV PET is the latest development in PET instrumentation, many studies are ongoing that expl...

    Authors: Joyce van Sluis, Ronald Borra, Charalampos Tsoumpas, Johannes H. van Snick, Mostafa Roya, Dik ten Hove, Adrienne H. Brouwers, Adriaan A. Lammertsma, Walter Noordzij, Rudi A.J.O. Dierckx, Riemer H.J.A. Slart and Andor W.J.M. Glaudemans
    Citation: Cancer Imaging 2022 22:69
  21. Magnetic resonance imaging (MRI) can be used to diagnose breast cancer. Diffusion weighted imaging (DWI) and the apparent diffusion coefficient (ADC) can reflect tumor microstructure in a non-invasive manner. ...

    Authors: Alexey Surov, Maciej Pech, Hans-Jonas Meyer, Almir G. V. Bitencourt, Hiroshi Fujimoto, Gabrielle C. Baxter, Gorane Santamaría, Fiona J. Gilbert and Andreas Wienke
    Citation: Cancer Imaging 2022 22:68
  22. Nodal size is an important imaging criterion for differentiating benign from malignant nodes in the head and neck cancer staging. This study evaluated the size of normal nodes in less well-documented nodal gro...

    Authors: Qi Yong H. Ai, Tiffany Y. So, Kuo Feng Hung and Ann D. King
    Citation: Cancer Imaging 2022 22:66
  23. To observe the diagnostic efficacy of preoperative fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) upon venous tumor thrombus (VTT) in patients with renal cell c...

    Authors: Silu Chen, Yanyan Zhao, Qi Tang, Caixia Wu, Aixiang Wang, Linlin Ma, Xi Zhang, Jinzhi Chen, Yuan Gao, Xuhe Liao, Ninghan Feng, Yan Fan, Jianhua Zhang, Xuesong Li and Meng Liu
    Citation: Cancer Imaging 2022 22:65
  24. Parathyroid carcinoma (PC) and atypical parathyroid tumor (APT) are rare parathyroid disorders carrying the risk of recurrence of varying degrees. This study aims to explore the value of 2D-shear wave elastogr...

    Authors: Ruifeng Liu, Luying Gao, Xinlong Shi, Liyuan Ma, Ou Wang, Weibo Xia, Ya Hu, Yu Xia and Yuxin Jiang
    Citation: Cancer Imaging 2022 22:64
  25. Advances in molecular diagnostics accomplished the discovery of two malignant glioma entities harboring alterations in the H3 histone: diffuse midline glioma, H3 K27-altered and diffuse hemispheric glioma, H3 ...

    Authors: Arian Lasocki, Gehad Abdalla, Geoffrey Chow and Stefanie C. Thust
    Citation: Cancer Imaging 2022 22:63
  26. Esophageal fistula is one of the most serious complications of chemotherapy or chemoradiotherapy (CRT) for advanced esophageal cancer. This study aimed to evaluate the performance of quantitative computed tomo...

    Authors: Yan-Jie Shi, Chang Liu, Yi-Yuan Wei, Xiao-Ting Li, Lin Shen, Zhi-Hao Lu and Ying-Shi Sun
    Citation: Cancer Imaging 2022 22:62
  27. Lymphovascular invasion (LVI) predicts a poor outcome of breast cancer (BC), but LVI can only be postoperatively diagnosed by histopathology. We aimed to determine whether quantitative parameters of dynamic co...

    Authors: Tianfu Lai, Xiaofeng Chen, Zhiqi Yang, Ruibin Huang, Yuting Liao, Xiangguang Chen and Zhuozhi Dai
    Citation: Cancer Imaging 2022 22:61
  28. Survivors of testicular cancer may experience long-term morbidity following treatment. There is an unmet need to investigate techniques that can differentiate individuals who need additional therapy from those...

    Authors: Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, Guy C Toner, Jeremy Goad, Nathan Lawrentschuk, Keen-Hun Tai, Jeremy H Lewin and Ben Tran
    Citation: Cancer Imaging 2022 22:58
  29. Breast cancer screening is essential in detecting breast tumors, however, the examination is stressful. In this study we analyzed whether humor enhances patient satisfaction.

    Authors: Elisabeth Sartoretti, Thomas Sartoretti, Dow Mu Koh, Sabine Sartoretti-Schefer, Sebastian Kos, Romana Goette, Ricardo Donners, Robyn Benz, Johannes M. Froehlich, Simon Matoori, Peter Dubsky, Tino Plümecke, Rosemarie Forstner, Willibald Ruch, Matthias Meissnitzer, Klaus Hergan…
    Citation: Cancer Imaging 2022 22:57
  30. This study aimed to evaluate the diagnostic capacity of apparent diffusion coefficient (ADC) in predicting pathological Masaoka and T stages in patients with thymic epithelial tumors (TETs).

    Authors: Chao-Chun Chang, Chia-Ying Lin, Li-Ting Huang, Ming-Tsung Chuang, Ying-Hung Lu, Wei-Li Huang, Ying-Yuan Chen, Wu-Wei Lai, Yau-Lin Tseng and Yi-Ting Yen
    Citation: Cancer Imaging 2022 22:56
  31. To compare the diagnostic performance of international hepatocellular carcinoma (HCC) guidelines with gadoxetic acid-enhanced MRI (EOB-MRI) and contrast-enhanced Computed tomography (CECT) and their impact on ...

    Authors: Devang Odedra, Ali Babaei Jandaghi, Rajesh Bhayana, Khaled Y. Elbanna, Osvaldo Espin-Garcia, Sandra E. Fischer, Anand Ghanekar, Gonzalo Sapisochin and Kartik S. Jhaveri
    Citation: Cancer Imaging 2022 22:55
  32. Early tumor shrinkage (ETS) has been identified as a promising imaging biomarker for patients undergoing immunotherapy for several cancer entities. This study aimed to validate the potential of ETS as an imagi...

    Authors: Lukas Müller, Simon Johannes Gairing, Roman Kloeckner, Friedrich Foerster, Eva Maria Schleicher, Arndt Weinmann, Jens Mittler, Fabian Stoehr, Moritz Christian Halfmann, Christoph Düber, Peter Robert Galle and Felix Hahn
    Citation: Cancer Imaging 2022 22:54
  33. To compare [68Ga]PSMA-11 PET-CT, [68Ga]PSMA-11 PET-MRI and MRI in a cohort of prostate cancer (PCa) patients in biochemical recurrence after initial curative therapy.

    Authors: P. A. Glemser, L. T. Rotkopf, C. H. Ziener, B. Beuthien-Baumann, V. Weru, A. Kopp-Schneider, H. P. Schlemmer, A. Dimitrakopoulou-Strauss and C. Sachpekidis
    Citation: Cancer Imaging 2022 22:53
  34. In nasal or sinonasal tumors, orbital invasion beyond periorbita by the tumor is one of the important criteria in the selection of the surgical procedure. We investigated the usefulness of the convolutional ne...

    Authors: Junichi Nakagawa, Noriyuki Fujima, Kenji Hirata, Minghui Tang, Satonori Tsuneta, Jun Suzuki, Taisuke Harada, Yohei Ikebe, Akihiro Homma, Satoshi Kano, Kazuyuki Minowa and Kohsuke Kudo
    Citation: Cancer Imaging 2022 22:52
  35. To develop a radiomics model based on pretreatment whole-liver portal venous phase (PVP) contrast-enhanced CT (CE-CT) images for predicting metachronous liver metastases (MLM) within 24 months after rectal can...

    Authors: Meng Liang, Xiaohong Ma, Leyao Wang, Dengfeng Li, Sicong Wang, Hongmei Zhang and Xinming Zhao
    Citation: Cancer Imaging 2022 22:50
  36. Molecular imaging technologies are increasingly used to diagnose, monitor, and guide treatment of i.e., cancer. In this review, the current status and future prospects of the use of molecular imaging as an in...

    Authors: Imke Boekestijn, Matthias N. van Oosterom, Paolo Dell’Oglio, Floris H. P. van Velden, Martin Pool, Tobias Maurer, Daphne D. D. Rietbergen, Tessa Buckle and Fijs W. B. van Leeuwen
    Citation: Cancer Imaging 2022 22:48
  37. To combine intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) parameters for the evaluation of radiotherapy response in rabbit VX2 malignant bone tumor model.

    Authors: Jia Guo, Weikai Sun, Cheng Dong, Zengjie Wu, Xiaoli Li, Ruizhi Zhou and Wenjian Xu
    Citation: Cancer Imaging 2022 22:47
  38. To establish a nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodules (SSNs) according to the 2021 WHO classification.

    Authors: Qilong Song, Biao Song, Xiaohu Li, Bin Wang, Yuan Li, Wu Chen, Zhaohua Wang, Xu Wang, Yongqiang Yu, Xuhong Min and Dongchun Ma
    Citation: Cancer Imaging 2022 22:46
  39. We aimed to evaluate the prevalence of incidental 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT (SSTR PET/CT) findings, their clinical significance in the need for follow-up, and their risk...

    Authors: Morten Bentestuen, Farid Gossili, Charlotte Elberling Almasi and Helle Damgaard Zacho
    Citation: Cancer Imaging 2022 22:44
  40. High early recurrence (ER) of hepatocellular carcinoma (HCC) after microwave ablation (MWA) represents a sign of aggressive behavior and severely worsens prognosis. The aim of this study was to estimate the ou...

    Authors: Zhaohe Zhang, Jie Yu, Sisi Liu, Linan Dong, Tiefang Liu, Haiyi Wang, Zhiyu Han, Xiaojing Zhang and Ping Liang
    Citation: Cancer Imaging 2022 22:42

Official journal of

Annual Journal Metrics

Download journal leaflet